Prevalence of thyroid dysfunction in patients with acute atrial fibrillation attended at a cardiology emergency room
Keywords:
Atrial fibrillation, Thyroid dysfunction, HyperthyroidismAbstract
CONTEXT: Atrial fibrillation occurs frequently in patients with thyrotoxicosis, while it has low prevalence in adults of the general population. The prevalence of thyroid dysfunction in subjects with atrial fibrillation is 0 to 24%, a wide variation that is attributed to the different methodologies applied. However, continuous use of amiodarone in patients with previous atrial fibrillation may interfere with these prevalence rates. OBJECTIVE: In this study, we present the prevalence of thyroid dysfunction in adult patients who presented at a cardiac emergency room with acute atrial fibrillation, using a sensitive thyroid-stimulating hormone (TSH) assay and triiodothyronine (T3) and thyroxine (T4) determination. TYPE OF STUDY: Cross-sectional study SETTING: Emergency room of a tertiary care facility. PARTICIPANTS: A total of 72 patients with atrial fibrillation who presented at the emergency room not more than 48 hours after its onset. PROCEDURES: A standardized questionnaire and 12- lead electrocardiogram were applied, and T3, T4 and TSH were determined. MAIN MEASUREMENTS: TSH, T3 and T4 determination. RESULTS: Among these patients, 16.6% had altered thyroid function tests: 6.9% had hyperthyroidism, 5.6% hypothyroidism and 4.2% had increased T4 levels, by means of amiodarone use. CONCLUSION: The high prevalence of thyroid dysfunction in our study, especially hyperthyroidism, suggests that routine thyroid testing with sensitive thyroid-stimulating hormone assay is required in patients with acute atrial fibrillation.
Downloads
References
Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992;327(2):94-8.
Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98(5):476-84.
Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic fea- tures of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306(17):1018-22.
Siebers MJ, Drinka PJ, Vergauwen C. Hyperthyroidism as a cause of atrial fibrillation in long-term care. Arch Int Med 1992;152(10):2063-4.
Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in insti- tutionalized elderly patients with atrial fibrillation. Arch Int Med 1984;144(9):1758-60.
Rubenstein HA, Butler VP, Werner SC. Progressive decrease in serum triiodothyronine concentrations with human aging: ra- dioimmunoassay following extraction of serum. J Clin Endocrinol Metab 1973;37(2):247-53.
Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Int Med 1991;151(1):165-8.
Lima N, Medeiros Neto G. Transient thyrotoxicosis in endemic goiter patients following exposure to a normal iodine intake. Clin Endocrinol (Oxf ) 1984;21(6):631-7.
Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev 1982;3(2):164-217.
Wians FH, Jacobson JM, Dev J, Heald JI, Ortiz G. Thyrotroph function assessed by sensitive measurement of thyrotropin with three immunoradiometric assay kits: analytical evaluation and comparison with the thyroliberin test. Clin Chem 1988;34(3):568-75.
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older per- sons. N Engl J Med 1994;331(19):1249-52.
Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of sub- clinical thyroid dysfunction on the heart. Ann Intern Med 2002;137(11):904-14.
Biondi B, Fazio S, Palmieri EA, et al. Effects of chronic sub- clinical hyperthyroidism from levothyroxine on cardiac mor- phology and function. [Effetti dell’ipertiroidismo subclinico cronico da terapia con levotiroxina su morfologia e funzione cardiaca]. Cardiologia 1999;44(5):443-9.
Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999;84(6):2064-7.
Sgarbi JA, Scandiuzzi SM, Villaça F, Mota KL, Villar HCC, Romaldini JH. Efeitos cardíacos do tratamento do hipertireoidismo subclínico (HSC) com metimazol (MMI). 9o Encontro Brasileiro de Tireóide. [Proceedings of the 9th Brazilian Thyroid Meeting]. Gramado, April 28 to May 1, 2000; p. 7.
Fagerberg B, Lindstedt G, Stromblad SO, et al. Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition? Clin Chem 1990;36(4):620-7.
Krahn AD, Klein GJ, Kerr CR, et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med 1996;156(19):2221-4.
Barbisan JN, Fuchs FD, Sabedotti M, Lidke PER, Carballo M. Eficácia da procainamida intravenosa na reversão da fibrilação atrial aguda: resultados de um ensaio clínico, duplo cego, controlado por placebo. Arq Bras Cardiol 2000;74(I):42.
Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Int Med 2000;160(11):1573-5.
Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estima- tion of tissue hypothyroidism by a new clinical score: evalua- tion of patients with various grades of hypothyroidism and con- trols. J Clin Endocrinol Metab 1997;82(3):771-6.
Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a cor- rectable cause of “idiopathic” atrial fibrillation. Am J Cardiol 1979;44(1):9-12.
Ciaccheri M, Cecchi F, Arcangeli C, Dolara A, Zuppiroli A, Pieroni C. Occult thyrotoxicosis in patients with chronic and paroxysmal isolated atrial fibrillation. Clin Cardiol 1984;797):413-6.
Giladi M, Aderka D, Zeligman-Melatzki L, Finkelstein A, Ayalon D, Levo Y. Is idiopathic atrial fibrillation caused by occult thyrotoxicosis? A study of one hundred consecutive patients with atrial fibrillation. Int J Cardiol 1991;30(3):309-13.
Davies AB, Williams I, John R, Hall R, Scanlon MF. Diagnos- tic value of thyrotrophin releasing hormone tests in elderly pa- tients with atrial fibrillation. Br Med J 1985;291(6498):773-6.
Franklyn JA, Black EG, Betteridge J, Sheppard MC. Compari- son of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, pa- tients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab 1994;78(6):1368-71.
Komiya N, Isomoto S, Nakao K, Hayano M, Yano K. Electro- physiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol (Oxf ) 2002;56(1):39-44.
Kendall-Taylor P. Thyroid function tests. Tests must still be done in possible thyroid dysfunction. BMJ 2000;321(7268):1080; discussion 1081-2.
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) con- centrations in the elderly in the United Kingdom. Clin Endocrinol 1991;34(1):77-83.
Mendonça SCL, Jorge PT. Estudo da função tireoidiana em uma população com mais de 50 anos. [Thyroid function stud- ies in a population sample over 50 years of age]. Arq Bras Endocrinol Metab 2002;46(5):557-65.
Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Int Med 1990;150(4):785-7.
Medeiros Neto G. Programa de correção da carência crônica de iodo no Brasil através da adição de iodo ao sal: do sucesso inicial à incerteza atual. [Correction programm of iodine chronic dep- rivation in Brazil, by addtion of iodine as sodium chloride di- etary: of the sucess as actual uncertainty]. Arq Bras Endocrinol Metab 1998;42(3):235-7.
